A retrospective survival analysis examined the association of acetylcholinesterase inhibitors with mortality in a large cohorts of patients with Alzheimer’s disease from one of the largest healthcare providers in Europe in an evaluation for mental disorders and dementia. This evidence concerns the gene ACHE and dementia.